Cargando…

Dietary nitrate improves jaw bone remodelling in zoledronate‐treated mice

Bisphosphonate‐related osteonecrosis of the jaw (BRONJ) is a serious complication that occurs in patients with osteoporosis or metastatic bone cancer treated with bisphosphonate. There is still no effective treatment and prevention strategy for BRONJ. Inorganic nitrate, which is abundant in green ve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Wen, Gu, Jianyu, Xu, Shihan, Zhang, Chunmei, Wang, Jinsong, Wang, Songlin, Xu, Junji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334281/ https://www.ncbi.nlm.nih.gov/pubmed/36810909 http://dx.doi.org/10.1111/cpr.13395

Ejemplares similares

Dietary Inorganic Nitrate Protects Hepatic Ischemia-Reperfusion Injury Through NRF2-Mediated Antioxidative Stress
por: Li, Shaorong, et al.
Publicado: (2021)

Dietary nitrate supplementation prevents radiotherapy-induced xerostomia
por: Feng, Xiaoyu, et al.
Publicado: (2021)

Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice
por: Bonnet, Nicolas, et al.
Publicado: (2013)

Bone structure and remodelling in stroke patients: Early effects of zoledronate()
por: Poole, Kenneth E.S., et al.
Publicado: (2009)

Bone Morphogenetic Protein 4 Alleviates DSS-Induced Ulcerative Colitis Through Activating Intestinal Stem Cell by Target ID3
por: Hu, Lei, et al.
Publicado: (2021)

Zoledronate‐Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma
por: Lundberg, A.P., et al.
Publicado: (2016)

Dental extraction following zoledronate, induces osteonecrosis in rat´s jaw
por: Vidal-Gutiérrez, Ximena, et al.
Publicado: (2017)

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
por: Moradi, Saeed, et al.
Publicado: (2023)

Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
por: Chen, Xin, et al.
Publicado: (2021)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
por: Alsalih, Aya, et al.
Publicado: (2021)

Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice
por: Li, Xiaoyu, et al.
Publicado: (2022)

A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma
por: Howie, R. Nicole, et al.
Publicado: (2015)

Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization
por: Biguetti, Claudia Cristina, et al.
Publicado: (2019)

Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid
por: Ciobanu, George Adrian, et al.
Publicado: (2023)

A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors
por: Manfredi, Maddalena, et al.
Publicado: (2017)

Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Tooth Extractions Sites Ameliorates the Incidence of Osteonecrotic Jaw-Like Lesions in Zoledronic Acid-Treated Rats
por: Rodríguez-Lozano, Francisco Javier, et al.
Publicado: (2020)

Zoledronic acid regulates the synthesis and secretion of IL-1β through Histone methylation in macrophages
por: Yang, Xiaojie, et al.
Publicado: (2020)

Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid
por: Yanae, Masashi, et al.
Publicado: (2017)

Data in support of the bone analysis of NOD–SCID mice treated with zoledronic acid and prednisolone
por: Hori, Naoko, et al.
Publicado: (2016)

Platelet-Rich Plasma in Treatment of Zoledronic Acid-Induced Bisphosphonate-related Osteonecrosis of the Jaws
por: Sarkarat, Farzin, et al.
Publicado: (2014)

Denosumab/ibandronic acid/zoledronic acid: Medication-related osteonecrosis of jaw: case report
Publicado: (2021)

Effect of intravenous administration of zoledronic acid on jaw bone density in cases having skeletal metastasis: A prospective clinical study
por: Jain, Veena, et al.
Publicado: (2019)

Skeletal Site-specific Effects of Zoledronate on in vivo Bone Remodeling and in vitro BMSCs Osteogenic Activity
por: Gong, Xue, et al.
Publicado: (2017)

Infection, vascularization, remodelling - are stem cells the answers for bone diseases of the jaws?
por: Handschel, Jörg, et al.
Publicado: (2011)

Controlled Delivery of Zoledronate Improved Bone Formation Locally In Vivo
por: Gou, Wenlong, et al.
Publicado: (2014)

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Negative effect of zoledronic acid on tendon-to-bone healing: In vivo study of biomechanics and bone remodeling in a rat model
por: Hjorthaug, Geir Aasmund, et al.
Publicado: (2018)

An Approach for the Prevention, Diagnosis, and Treatment of Jaw Osteonecrosis: Report of a Case Associated with Zoledronic Acid
por: de Alexandria Santos, Danila S., et al.
Publicado: (2020)

Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis
por: Limones, Alvaro, et al.
Publicado: (2020)

Decellularized Swine Dental Pulp as a Bioscaffold for Pulp Regeneration
por: Hu, Lei, et al.
Publicado: (2017)

The effect of zoledronate during bone healing
por: Matos, Marcos Almeida, et al.
Publicado: (2010)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

Zoledronate combined metal-organic frameworks for bone-targeting and drugs deliveries
por: Pan, Yixiao, et al.
Publicado: (2022)

Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review
por: Kourie, Hampig Raphael, et al.
Publicado: (2015)

Risk Factors for Medication-Related Osteonecrosis of the Jaw—A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid
por: Ciobanu, George Adrian, et al.
Publicado: (2023)

Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis
por: Messer, Jonathan G., et al.
Publicado: (2019)

A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw
por: Bullock, George, et al.
Publicado: (2022)

Effects of Zoledronic Acid on Physiologic Bone Remodeling of Condylar Part of TMJ: A Radiologic and Histomorphometric Examination in Rabbits
por: Tatli, Ufuk, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d71pc2ffa1h2mksrv3kcst13e8